Summit Partners Public Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-64,400
Closed -$6.53M 92
2020
Q2
$6.53M Buy
+64,400
New +$5.76M 0.39% 68
2019
Q4
Sell
-100,000
Closed -$3.73M 83
2019
Q3
$3.73M Buy
+100,000
New +$3.89M 0.37% 75

Other funds holding DXCM

Summit Partners Public Asset Management's DXCM Position: Q3 2023 in Review

Summit Partners Public Asset Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 340,233 shares — an estimated $43.7M sold.

Summit Partners Public Asset Management first reported a position in DXCM in Q1 2023 and held it in 2 quarters. The position peaked at $43.7M in Q2 2023. 904 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Summit Partners Public Asset Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 340,233 DexCom shares in Q3 2023, an estimated $43.7M.
  • Summit Partners Public Asset Management first reported a position in DexCom in Q1 2023 and held it in 2 quarters.
  • Summit Partners Public Asset Management's DexCom position peaked at $43.7M in Q2 2023.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Summit Partners Public Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.